Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Fortrea to acquire Worldwide's Early Phase division
PUBLIC · FTRESep 03, 2026•about 7 hours ago
Acquiring Company
Fortrea
Acquired Company
Worldwide Clinical Trials
Research Triangle ParkResearch Triangle ParkBiotechnologyHealth CareMedicalBiotechnologyHealth Care
Description
Fortrea has signed an agreement to acquire Worldwide Clinical Trials' Early Phase Services division for approximately $45 million. This acquisition will enhance Fortrea’s clinical development capabilities, adding significant laboratory and clinical facilities. The transaction is aimed at strengthening their service offerings in North America. Completion is subject to regulatory approvals.
Company Information
Company
Fortrea
Location
Research Triangle Park, North Carolina, United States
About
As a provider of comprehensive Phase I through IV clinical trial management, clinical pharmacology, patient access solutions and other enabling services, Fortrea partners with emerging and large biopharma and medical device and diagnostic companies to drive healthcare innovation throughout the world. Harnessing our passion for scientific rigor and decades of clinical trial experience, we navigate obstacles with agility and ease. We believe in advancing health equity by creating diverse and inclusive clinical trials that eliminate gaps in participation. We are problem-solvers and creative thinkers, committed to opening the doors between promising ideas and proven therapies.
Don't miss Fortrea's next move
Get an email the moment Fortrea makes an acquisition, hires an exec, or expands, usually minutes after it happens.
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed
Frequently asked
Who acquired Worldwide Clinical Trials?
Worldwide Clinical Trials was acquired by Fortrea, based in Research Triangle Park. The deal was reported on September 3, 2026. Fortrea is publicly traded (FTRE) and operates in Biotechnology.
When did Fortrea acquire Worldwide Clinical Trials?
Fortrea's acquisition of Worldwide Clinical Trials was reported on September 3, 2026. Fortrea has signed an agreement to acquire Worldwide Clinical Trials' Early Phase Services division for approximately $45 million. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Worldwide Clinical Trials do?
Worldwide Clinical Trials (Worldwide) is a global full-service contract research organization (CRO). It is privately held, operating in Biotechnology, and is based in Research Triangle Park.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
Research Triangle Park